Go Pro
→ Here’s the stock symbol I’ve promised (From Stansberry Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alvotech stock logo
ALVOW
Alvotech
$0.27
$0.25
$0.12
▼
$3.00
N/AN/A4,498 shs100 shs
Apollomics, Inc. stock logo
APLMW
Apollomics
$0.01
$0.02
$0.01
▼
$0.23
N/AN/A55,136 shs2,563 shs
Aravive, Inc stock logo
ARAV
Aravive
$0.04
$0.04
$0.04
▼
$2.46
N/AN/AN/AN/A
enGene Holdings Inc. stock logo
ENGNW
enGene
$0.26
+5.6%		$0.28
$0.11
▼
$4.20
N/AN/A15,941 shs100 shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alvotech stock logo
ALVOW
Alvotech
-27.03%-17.51%+22.67%+34.80%-75.23%
Apollomics, Inc. stock logo
APLMW
Apollomics
0.00%-3.33%+4.50%-9.38%-39.27%
Aravive, Inc stock logo
ARAV
Aravive
0.00%0.00%0.00%0.00%0.00%
enGene Holdings Inc. stock logo
ENGNW
enGene
+2.00%+28.14%-40.71%-8.86%-71.02%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alvotech stock logo
ALVOW
Alvotech
$0.27
$0.25
$0.12
▼
$3.00
N/AN/A4,498 shs100 shs
Apollomics, Inc. stock logo
APLMW
Apollomics
$0.01
$0.02
$0.01
▼
$0.23
N/AN/A55,136 shs2,563 shs
Aravive, Inc stock logo
ARAV
Aravive
$0.04
$0.04
$0.04
▼
$2.46
N/AN/AN/AN/A
enGene Holdings Inc. stock logo
ENGNW
enGene
$0.26
+5.6%		$0.28
$0.11
▼
$4.20
N/AN/A15,941 shs100 shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alvotech stock logo
ALVOW
Alvotech
-27.03%-17.51%+22.67%+34.80%-75.23%
Apollomics, Inc. stock logo
APLMW
Apollomics
0.00%-3.33%+4.50%-9.38%-39.27%
Aravive, Inc stock logo
ARAV
Aravive
0.00%0.00%0.00%0.00%0.00%
enGene Holdings Inc. stock logo
ENGNW
enGene
+2.00%+28.14%-40.71%-8.86%-71.02%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alvotech stock logo
ALVOW
Alvotech
0.00
N/AN/AN/A
Apollomics, Inc. stock logo
APLMW
Apollomics
0.00
N/AN/AN/A
Aravive, Inc stock logo
ARAV
Aravive
0.00
N/AN/AN/A
enGene Holdings Inc. stock logo
ENGNW
enGene
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alvotech stock logo
ALVOW
Alvotech
$491.95MN/AN/AN/AN/AN/A
Apollomics, Inc. stock logo
APLMW
Apollomics
$8.50MN/AN/AN/AN/AN/A
Aravive, Inc stock logo
ARAV
Aravive
N/AN/AN/AN/AN/AN/A
enGene Holdings Inc. stock logo
ENGNW
enGene
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alvotech stock logo
ALVOW
Alvotech
N/AN/AN/AN/AN/AN/AN/AN/A11/11/2026 (Estimated)
Apollomics, Inc. stock logo
APLMW
Apollomics
N/AN/AN/AN/AN/AN/AN/AN/A9/24/2026 (Estimated)
Aravive, Inc stock logo
ARAV
Aravive
N/A-$0.90N/AN/AN/AN/AN/AN/AN/A
enGene Holdings Inc. stock logo
ENGNW
enGene
N/AN/AN/AN/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Alvotech stock logo
ALVOW
Alvotech
N/AN/AN/AN/AN/A
Apollomics, Inc. stock logo
APLMW
Apollomics
N/AN/AN/AN/AN/A
Aravive, Inc stock logo
ARAV
Aravive
N/AN/AN/AN/AN/A
enGene Holdings Inc. stock logo
ENGNW
enGene
$1.58598.86%N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Alvotech stock logo
ALVOW
Alvotech
N/A
Apollomics, Inc. stock logo
APLMW
Apollomics
N/A
Aravive, Inc stock logo
ARAV
Aravive
35.80%
enGene Holdings Inc. stock logo
ENGNW
enGene
N/A

Insider Ownership

CompanyInsider Ownership
Alvotech stock logo
ALVOW
Alvotech
N/A
Apollomics, Inc. stock logo
APLMW
Apollomics
N/A
Aravive, Inc stock logo
ARAV
Aravive
60.40%
enGene Holdings Inc. stock logo
ENGNW
enGene
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Alvotech stock logo
ALVOW
Alvotech
4N/AN/ANot Optionable
Apollomics, Inc. stock logo
APLMW
Apollomics
59N/AN/ANot Optionable
Aravive, Inc stock logo
ARAV
Aravive
20N/AN/ANo Data
enGene Holdings Inc. stock logo
ENGNW
enGene
31N/AN/AN/A

Recent News About These Companies

Under The 2027 GMC Sierra's Hood: Four Engines, 10-Speeds Standard
September 22 at 5:36 PM  |  autoguide.comA
2027 Chevrolet Colorado and GMC Canyon Gain Upgraded Engine
September 22 at 5:36 PM  |  autoguide.comA
The Reason Why Short Trips Are So Hard On Turbocharged Engines
September 22 at 7:34 AM  |  slashgear.comS
Bet Shemesh Engines: Great Growth, But The Stock Is Not A Buy Yet
September 22 at 2:34 AM  |  seekingalpha.comhttps://seekingalpha.com/article/4948488-bet-shemesh-engines-great-growth-but-the-stock-is-not-a-buy-yet
When Did Cummins Make Its First Engine? (And What Was It Used For?)
September 22 at 2:34 AM  |  msn.comhttps://www.msn.com/en-us/news/other/when-did-cummins-make-its-first-engine-and-what-was-it-used-for/ar-AA2cHYuj
If your diesel engine feels sluggish under load, this might be why
September 21 at 4:33 PM  |  msn.comhttps://www.msn.com/en-us/general/general/if-your-diesel-engine-feels-sluggish-under-load-this-might-be-why/ar-AA2cHDxN
Why Are Mazda's Four-Cylinder Skyactiv-G Engines So Reliable?
September 21 at 11:33 AM  |  msn.comhttps://www.msn.com/en-us/news/other/why-are-mazdas-four-cylinder-skyactiv-g-engines-so-reliable/ar-AA2cGhhn
What Does Fogging Oil Do To An Engine?
September 21 at 11:33 AM  |  autos.yahoo.comhttps://autos.yahoo.com/ownership/articles/does-fogging-oil-engine-094500662.html
Why do bikers rev their motorcycle engines at stop lights?
September 21 at 11:33 AM  |  msn.comhttps://www.msn.com/en-us/news/other/why-do-bikers-rev-their-motorcycle-engines-at-stop-lights/ar-AA2cFGel
These 7 4-cylinder engines are nearly indestructible
September 20 at 10:40 PM  |  msn.comhttps://www.msn.com/en-us/news/other/these-7-4-cylinder-engines-are-nearly-indestructible/ar-AA2cDaYh
This 1,200-HP Crate Engine Could Turn Your Humble Chevy Into A Hypercar Killer
September 20 at 5:39 PM  |  carbuzz.comC
When Subaru killed the EJ engine (and what replaced it)
September 20 at 5:39 PM  |  msn.comhttps://www.msn.com/en-us/news/other/when-subaru-killed-the-ej-engine-and-what-replaced-it/ar-AA2cCHwc
Why It Can Cost So Much To Replace Your Car's Engine Mounts
September 20 at 7:37 AM  |  msn.comhttps://www.msn.com/en-us/news/other/why-it-can-cost-so-much-to-replace-your-cars-engine-mounts/ar-AA2cBElZ
Nearly a million GM trucks are under federal investigation for engines failing twice
September 20 at 7:37 AM  |  msn.comhttps://www.msn.com/en-us/news/other/nearly-a-million-gm-trucks-are-under-federal-investigation-for-engines-failing-twice/ar-AA2cBzF0
General Motors Unveils New Engine Lineup for 2027 Pickup Trucks
September 20 at 7:37 AM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/general-motors-unveils-engine-lineup-054147889.html
The Biggest Yamaha Motorcycle Engine In 2026
September 20 at 2:36 AM  |  msn.comhttps://www.msn.com/en-us/news/other/the-biggest-yamaha-motorcycle-engine-in-2026/ar-AA2cym5p
3 of the worst issues with boxer engines in particular
September 20 at 2:36 AM  |  msn.comhttps://www.msn.com/en-us/autos/general/3-of-the-worst-issues-with-boxer-engines-in-particular/ar-AA2cAgNe
The Harley-Davidson Engine That Deserves More Credit Than the Milwaukee-Eight
September 20 at 2:36 AM  |  topspeed.comT
Who Makes Yanmar Diesel Engines And Where Are They Manufactured?
September 20 at 2:36 AM  |  msn.comhttps://www.msn.com/en-us/news/other/who-makes-yanmar-diesel-engines-and-where-are-they-manufactured/ar-AA2cAazJ
2027 Chevy Silverado 1500, GMC Sierra 1500 V8 Engines Keep This Unloved Fuel-Saving Feature
September 19, 2026  |  gmauthority.comG

New MarketBeat Followers Over Time

Media Sentiment Over Time

Alvotech stock logo

Alvotech NASDAQ:ALVOW

$0.27 0.00 (0.00%)
As of 09/22/2026 01:29 PM Eastern

Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, and other indications; AVT04, a biosimilar to Stelara to treat various inflammatory conditions comprising psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, and other indications; AVT06, a biosimilar to Eylea to treat various conditions, such as age-related macular degeneration, macular edema, and diabetic retinopathy; and AVT03, a biosimilar to Xgeva and Prolia, which is in the pre-clinical phase to treat prevent bone fracture, spinal cord compression, and the need for radiation or bone surgery in patients with certain types of cancer, as well as prevent bone loss and increase bone mass. In addition, it offers AVT05, a biosimilar to Simponi and Simponi Aria, which is in early phase development to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and other indications; AVT16, a biosimilar to an Entyvio product; AVT23, a biosimilar to Xolair, which is in late-stage development to treat nasal polyps; and AVT33, a biosimilar to an Keytruda product. Alvotech was founded in 2013 and is based in Luxembourg, Luxembourg.

Apollomics stock logo

Apollomics NASDAQ:APLMW

$0.01 0.00 (0.00%)
As of 11:16 AM Eastern

Apollomics, Inc., a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways. Its solutions include tumor inhibitors, anti-cancer enhancers, and immune-oncology drugs. Apollomics, Inc. was formerly known as CBT Pharmaceuticals, Inc. and changed its name to Apollomics, Inc. in January 2019. Apollomics, Inc. was incorporated in 2016 and is based in Foster City, California with additional locations in Hangzhou and Shanghai, China and Southbank, Australia.

Aravive stock logo

Aravive NASDAQ:ARAV

$0.04 0.00 (0.00%)
As of 09/22/2026

Aravive, Inc., a clinical-stage biopharmaceutical company, develops transformative treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of platinum- resistant recurrent ovarian cancer; and in Phase Ib/II clinical trial for the treatment of clear cell renal cell carcinoma and pancreatic adenocarcinoma. The company also develops AVB-S6, a soluble Fc-fusion protein to block the activation of the GAS6-AXL signaling pathway. It has a license and collaboration agreement with WuXi Biologics (Hong Kong) Limited to identify and develop novel high-affinity bispecific antibodies targeting cancer and fibrosis; and license agreement with 3D Medicines Inc. to develop products that contain batiraxcept as the sole drug substance for the treatment of human oncological diseases in mainland China, Taiwan, Hong Kong, and Macau. The company was formerly known as Versartis, Inc. and changed its name to Aravive, Inc. in October 2018. Aravive, Inc. was incorporated in 2008 and is headquartered in Houston, Texas.

enGene stock logo

enGene NASDAQ:ENGNW

$0.26 +0.01 (+5.64%)
As of 11:05 AM Eastern
This is a fair market value price provided by Massive. Learn more.

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas